Recursion Pharmaceuticals, Inc. RXRX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s operating lease ROU assets?
- Recursion Pharmaceuticals, Inc. (RXRX) reported operating lease ROU assets of $42.82M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s operating lease ROU assets decreased by 19.5% year-over-year, from $53.19M to $42.82M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s operating lease ROU assets?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 8.3% compound annual growth rate (CAGR), from $32.9M to $45.34M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.